ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,889Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 614

$1.11M Total Retail Price of All Prescriptions

Rank: 2 out of 614

382 Patients Receiving at Least One Drug in Part D
12%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 382 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 871 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$125 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
ABILIFY 548 50 1 24
RISPERIDONE 514 21 2 22
VENLAFAXINE HCL ER 508 64 3 30
TRAZODONE HCL 454 38 4 20
FLUOXETINE HCL 409 76 5 27
BENZTROPINE MESYLATE 370 23 R 6 40
LITHIUM CARBONATE 336 40 7 61
CITALOPRAM HBR 332 50 8 14
GABAPENTIN 325 21 9 11
CLOZAPINE 269 25 10 80
QUETIAPINE FUMARATE 266 34 11 32
OLANZAPINE 252 32 12 49
SERTRALINE HCL 244 33 13 18
CYMBALTA 239 26 14 42
LAMOTRIGINE 225 12 15 34
BUPROPION HCL SR 208 20 16 45
BUSPIRONE HCL 200 30 17 62
DIVALPROEX SODIUM ER 199 0 18 52
PAROXETINE HCL 177 0 19 58
TOPIRAMATE 138 0 20 51
CARBAMAZEPINE 137 0 21 120
PERPHENAZINE 129 47 22 147
DIVALPROEX SODIUM 129 17 22 119
ZIPRASIDONE HCL 123 0 24 90
SEROQUEL 116 18 25 83
NORTRIPTYLINE HCL 115 34 26 202
FLUVOXAMINE MALEATE 115 0 26 165
DOXEPIN HCL 107 0 28 163
RISPERDAL CONSTA 94 13 29 153
HALOPERIDOL 89 0 30 104
ESCITALOPRAM OXALATE 88 0 31 77
MIRTAZAPINE 82 0 32 65
SEROQUEL XR 81 0 33 84
ZOLPIDEM TARTRATE 79 0 34 26
AMITRIPTYLINE HCL 75 0 R 35 82
BUPROPION XL 72 0 36 101
INVEGA SUSTENNA 65 0 37 232
TRIHEXYPHENIDYL HCL 65 13 R 37 166
AMANTADINE 59 0 39 247
LEVOTHYROXINE SODIUM 54 0 40 4
EFFEXOR XR 53 0 10 41 262
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.